Jeremy Grantham started to build up the position in Puma Biotechnology in Q2 2015 and continued to invest until Q4 2015. Since then they sold 2.9 Million shares. The investor completely sold their stake between Q1 2016 and Q2 2016.
Avg closing price
Price range
Sold -2.01 Million shares
Q2 2016
Avg closing price
$31.26
Price range
$21.87
-
$39.30
Sold 30.7% shares (-889 Thousand shares)
Q1 2016
Avg closing price
$45.19
Price range
$27.53
-
$73.54
Increased shares by 72.9% (+1.22 Million shares)
Q4 2015
Avg closing price
$78.49
Price range
$64.97
-
$92.91
Increased shares by 17.5% (+250 Thousand shares)
Q3 2015